August 24, 2026
Delix Therapeutics
Delix Therapeutics is a Boston-based developer of psychoplastogens.
- Round
- Series C
- Amount raised
- $85M
- Lead investor
- J&J
- Industry
- Biotechnology, Pharmaceuticals
- Headquarters
- Boston, MA
- Employees
- 24 employees
- Website
- delixtherapeutics.com
- View profile →
Source: Axios Pro Rata